-
Cas9 mRNA–gRNA Editing of LGMN in Breast Cancer
2026-08-23
The reference study developed a lipid nanoparticle strategy for co-delivering Cas9 mRNA and guide RNAs to disrupt LGMN, a metastasis-associated lysosomal protease gene. Its results connect transient CRISPR component delivery with impaired lysosomal/autophagic degradation and reduced breast cancer cell migration, invasion, and experimental lung metastasis.
-
Liraglutide and the Brain-Kidney AVP Axis
2026-08-22
Greenwood and colleagues connect liraglutide treatment with reduced circulating arginine vasopressin (AVP) in healthy humans and identify time- and sex-dependent synaptic phosphorylation changes in the rat pituitary. Their combined clinical, proteomic, reporter-assay, and renal analyses suggest that altered AVP release and aquaporin 2 regulation may contribute to the diuretic and natriuretic effects of GLP-1 receptor agonists.
-
N-MYC/eIF4G1 Survival Axis in inv(16) AML
2026-08-22
Peramangalam et al. identify an enhancer-dependent MYCN program and its downstream effector eIF4G1 as essential components of survival in inv(16) acute myeloid leukemia. The study connects CBFβ-SMMHC-associated transcriptional disruption to a therapeutically relevant N-MYC/eIF4G1 dependency using transcriptomic, chromatin, genetic, primary-cell, and patient-derived xenograft models.
-
Vidarabine Monohydrate: Antiviral Research Guide
2026-08-21
Vidarabine monohydrate is a purine nucleoside analog used to study inhibition of viral DNA synthesis and DNA replication interference. The C6377 product is supplied at ≥98% purity, is reported as DMSO-soluble but insoluble in water and ethanol, and is intended for research use only.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-08-20
This 2025 review integrates tumor hypoxia, metabolic reprogramming, nutrient competition, and immune dysfunction into a unified model of immunosuppressive tumor microenvironment formation. Its main practical value is to connect oxygen-regulated metabolism with immune-cell state, while emphasizing that metabolism-based therapies and biomarkers remain highly context dependent.
-
Protease Inhibitor Cocktail: Plant Stability
2026-08-20
This scenario-driven guide explains how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), SKU K1011, can reduce protein degradation during plant lysate preparation without being confused with a direct cell-viability reagent. It covers compatibility, dilution, controls, interpretation, and practical vendor-selection criteria for Western blotting and related protein assays.
-
FLAG tag Peptide: Workflow for Exosome Studies
2026-08-19
The FLAG tag Peptide (DYKDDDDK) combines selective recombinant protein detection with gentle competitive elution for native-complex workflows. This practical guide shows how to apply it to RAB31-centered exosome studies, compare single and 3X FLAG designs, and troubleshoot recovery, background, and cleavage problems.
-
Ellagic acid for CK2 and senescence assays
2026-08-19
Ellagic acid provides a mechanistic way to interrogate casein kinase 2 signaling, apoptosis, and oxidative-stress phenotypes alongside senescence-focused screens. This workflow combines biochemical target validation, cell-state selectivity testing, and machine-learning-informed assay design without assuming that CK2 inhibition alone proves senolytic activity.
-
(-)-JQ1 in N-MYC/eIF4G1 AML Assays
2026-08-18
(-)-JQ1 is a JQ1 stereoisomer that helps distinguish BET-dependent biology from scaffold, vehicle, and assay artifacts. This article connects rigorous negative-control design with the N-MYC/eIF4G1 survival axis identified in inv(16) AML research.
-
SmD2 Acetylation Rewires HCC Splicing and PARP Response
2026-08-18
A 2024 Nature Communications study identifies acetylation-dependent control of the core spliceosome protein SmD2 as a determinant of DNA-repair gene splicing and PARP-inhibitor response in hepatocellular carcinoma. The work connects p300-mediated SmD2 degradation and HDAC2-mediated stabilization with BRCA1/FANC cassette-exon regulation, supporting HDAC–PARP inhibitor combinations as a preclinical strategy in HCC.
-
DDX23 Restricts SVA Through Caspase Pathways
2026-08-17
A 2025 Journal of Virology study defines a two-sided interaction between the host RNA helicase DDX23 and Senecavirus A (SVA) proteins 3A and 2B. The work links residue-specific viral protein effects to distinct caspase-dependent degradation routes and validates their importance using recombinant viruses, providing a mechanistic framework for studying SVA immune evasion.
-
Ellagic acid in CK2 and senescence assays
2026-08-17
Ellagic acid enables mechanism-first interrogation of casein kinase 2 signaling, apoptosis, oxidative stress, and senescence phenotypes. This guide translates its biochemical selectivity and formulation constraints into practical workflows for target engagement, cancer biology research, and exploratory senolytic assays.
-
Esflurbiprofen: Fast-Onset Antidepressant Mechanism
2026-08-16
The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by disrupting the serotonin transporter–neuronal nitric oxide synthase interaction in the dorsal raphe nucleus. Its combination of mBRET-based screening, mouse stress models, mechanistic neurobiology, and resting-state fMRI provides a translational framework for targeting serotonergic autoreceptor feedback rather than relying on delayed SSRI adaptation.
-
ROS Assay Kit (DHE) for TrxR–MAPK Research
2026-08-15
The Reactive Oxygen Species Assay Kit provides a superoxide-focused readout for oxidative stress and redox signaling studies. This article explains how DHE fluorescence can connect TrxR–MAPK biology with immune and apoptosis research while preserving appropriate controls and interpretation limits.
-
Ellagic Acid: CK2 Mechanism and Research Workflow
2026-08-14
Ellagic acid is a polyphenolic, ATP-competitive CK2 inhibitor with a reported biochemical IC50 of 40 nM. Its defined chemical identity, DMSO solubility, and storage requirements support controlled cancer biology research, oxidative stress assays, apoptosis research, and mechanistic studies of the casein kinase 2 signaling pathway.